Representation of the elderly, women, and minorities in heart failure clinical trials.
about
Cardiovascular disease self-care interventionsEvidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groupsRecruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].Are racial and ethnic minorities less willing to participate in health research?Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase InhibitorsA systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific IslandersInforming evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseasesThe role of observational studies in optimizing the clinical management of chronic myeloid leukemiaComparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological studyGenome Sequence Variability Predicts Drug Precautions and Withdrawals from the MarketThe promotion of data sharing in pharmacoepidemiologyPrevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)Does random treatment assignment cause harm to research participants?Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.Strategies for recruiting African American men into prostate cancer screening studies.Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data.Routinely collected data and comparative effectiveness evidence: promises and limitations.Motives for (not) participating in a lifestyle intervention trial.N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study)Public interest in medical research participation: differences by volunteer status and study typeEffectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006.The impact of HIPAA authorization on willingness to participate in clinical research.Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell anemiaComparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney diseaseAssessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, UgandaOutcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).Can claims-based data be used to recruit black and Hispanic subjects into clinical trials?Risk stratification in very old adults: how to best gauge risk as the basis of management choices for patients aged over 80Heart failure in elderly patients: distinctive features and unresolved issues.The global perspective on irritable bowel syndrome: a Rome Foundation-World Gastroenterology Organisation symposium.Five-year outcome of surgical decompression of the lumbar spine without fusion.Strategic Planning for Recruitment and Retention of Older African Americans in Health Promotion Research Programs.Clinical and echocardiographic findings of newly diagnosed acute decompensated heart failure in elderly patientsEnrollment of women and minorities in NINDS trialsCognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
P2860
Q23923299-30F3BFCC-FC92-4034-8D0D-7EDF8E2FB41BQ24682167-44D39E43-0568-4D4A-ACA4-3D0539133997Q24814727-AB78A40B-98F6-4F64-8411-C2F5A0EE854BQ24814743-66945CD4-2C1A-49B2-90B6-79C7778B6DF6Q26863383-2A030231-B151-4E32-AF1A-C0A4BD0486D3Q27012187-C26FEF69-581E-4AA1-832E-735C6CDFDBEFQ27023214-16457BFC-5B1B-4403-BBE5-27831CD23568Q28085149-23D6478F-D31F-4362-8873-93A5F16929B6Q28533341-54261783-4C67-497C-B8BD-813A58439655Q28554426-C89926B1-7E67-4E51-8B58-87D72B80DD6AQ28651499-004DF4DD-B092-487F-9C7E-2510B451D0ADQ28742689-54A3C4B6-BE3B-4A78-98CA-CAF649EB192AQ28768704-059F08D2-D6F4-465D-A955-819C63BE77A2Q30235600-8816F37D-B219-4C03-86EA-15D01DC37014Q30251866-373775E7-CA4D-42BE-BB8D-4FA0E8097F47Q30434363-3F4D59D4-EB28-4A0E-88F1-3686C99E7C64Q30585651-9BAF56C4-D710-4699-8053-4F7BCDED2660Q30870018-7223A3D2-365C-4BE1-85D1-3D268086E910Q30986560-CDCD03AC-0653-43E1-980C-FF417654ED48Q31046490-5A400458-7A51-4DB7-AA11-61AE3F1F8E9AQ33327583-F38C42EB-0A14-4077-8A88-6F72AAE23E04Q33506869-665C0454-79EF-444F-9027-5C3555F3A46BQ33507726-880443D2-2751-48B0-B0C5-01AD7B2B7B68Q33575248-B6F4A1BA-F27D-45CB-BDA4-87D9F19970DBQ33576871-36F29BE0-E613-4843-A2F1-F7D01942F8A3Q33754385-B7B3DEE4-4A44-41CD-9DBA-268DA8E46122Q33894398-9838A18D-D594-4371-A340-7031FAE068B5Q33934737-5219BC04-96DB-4A96-9A96-591681474B94Q34017388-F45229A0-ED9A-4D74-BDC2-E649FFCF5769Q34067440-34ADF5EF-F6B4-400B-907C-06C1B568A8CFQ34069401-9E175AF1-7B57-4F38-8B31-AAECDDFEB70FQ34076454-4758076F-4D1C-42A3-A146-B1EAC2B58222Q34241222-87C223CF-74A2-4835-8E6F-1E43C04847ADQ34248538-BB77B735-EAC0-4C4D-B3F2-38AD20552AF6Q34312375-D3608A3A-272A-454E-9B43-A169315D6772Q34338129-943595C4-ABE7-4A2D-A9DA-F5A50F934472Q34399297-E75CCF87-D5FD-4F1B-96F0-87B9F5B523AEQ34474630-A9F27BF4-7657-4618-B1D8-2266E665F412Q34555467-27AEEE98-C967-4D08-8E70-3E4725DAA1B7Q34576103-8B33C19F-8DDB-4D37-A50A-1DE3722BBEEA
P2860
Representation of the elderly, women, and minorities in heart failure clinical trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Representation of the elderly, women, and minorities in heart failure clinical trials.
@ast
Representation of the elderly, women, and minorities in heart failure clinical trials.
@en
Representation of the elderly, women, and minorities in heart failure clinical trials.
@nl
type
label
Representation of the elderly, women, and minorities in heart failure clinical trials.
@ast
Representation of the elderly, women, and minorities in heart failure clinical trials.
@en
Representation of the elderly, women, and minorities in heart failure clinical trials.
@nl
prefLabel
Representation of the elderly, women, and minorities in heart failure clinical trials.
@ast
Representation of the elderly, women, and minorities in heart failure clinical trials.
@en
Representation of the elderly, women, and minorities in heart failure clinical trials.
@nl
P1476
Representation of the elderly, women, and minorities in heart failure clinical trials.
@en
P2093
Asefeh Heiat
Cary P Gross
P304
P356
10.1001/ARCHINTE.162.15.1682
P407
P577
2002-08-01T00:00:00Z